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Introduction
Liver sinusoidal endothelial cells (LSECs) possess
fenestrae whose number can be increased both in vitro and
in situ by depolymerizing the actin cytoskeleton [1]. Spe-
cially designed liposomes can be targeted with a high effi-
ciency to LSECs. These liposomes, which were surface
grafted with poly-anionized albumin (Aco-HSA) [2], can
be filled with various substances, such as microfilament-
disrupting drugs. This technique opens up attractive pos-
sibilities to modulate the liver sieve of LSECs with lipo-
some-encapsulated microfilament-disrupting drugs in
vivo.
The goal of this study was to alter the sieve's porosity by
using cytochalasin B-loaded Aco-HSA liposomes. The
increase in the liver sieve porosity induced by cytochalasin
B (CB) may be exploited therapeutically to improve the
extraction of atherogenic lipoproteins from the circula-
tion; or to enhance the efficiency of liposome-mediated
gene or drug delivery to hepatocytes.
Methods
For in vitro studies, LSECs of the male Wistar rat were iso-
lated by collagenase perfusion of the liver, isopycnic sedi-
mentation in a two-step Percoll gradient, and selective
adherence to different substrates. LSECs were cultured for
8 hours and treated with 0.025 microgram/ml CB or with
Aco-HSA CB-loaded liposomes for 30, 60 and 120 min-
utes. In order to visualize filamentous actin (F-actin),
LSECs grown on glass coverslips were stained with rhod-
amine-phalloidin [1]. Preparation of samples for EM-
investigation and computer-assisted analysis was done
according to standard protocols [1].
For in vivo experiments, male Wistar rats were injected
with 2 micromolar (i.e., 0.45 ml) of liposomes via the
penile vene. The liposomes were allowed to circulate for
two hours. Control animals received free Aco-HSA,
injected at the same concentration and volume. For all
experiments, CB-loaded Aco-HSA liposomes with the fol-
lowing characteristics were used: 4.48 micromolar total
lipid/ml; 47.6 micrograms Aco-HSA/micromolar total
lipid; 0.32 microgram CB/micromolar total lipid; 0.025
microgram CB/ml.
Results
F-actin staining showed a weak dissolution of cytoplasmic
F-actin when cultured LSECs were incubated with 0.025
microgram/ml free CB (Fig. 1A). SEM-investigation of CB-
treated LSECs showed a central lying nucleus and thin
cytoplasmic extensions that contained clustered fenestrae
in sieve plates (Fig. 1B). Computer-assisted analysis of
endothelial fenestration showed a moderate but signifi-
cant increase in the number of fenestrae per micrometer
squared, i.e., from 3.1 ± 0.4 to 4.3 ± 0.3 respectively (Fig.
2).
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Examination of Aco-HSA treated cells or rats did not
reveal any effects on the F-actin cytoskeleton (Fig. 3A) nor
on the number of fenestrae per area (Fig. 3C) or on the
ultrastructure of the liver sieve (Fig. 3E). When cultured
LSECs (Fig. 3B,3C,3D) or rats (Fig. 3F) were exposed for 2
hours to 2 micromolar Aco-HSA CB-loaded liposomes,
i.e., corresponding with 0.025 microgram/ml CB, no
effect on the F-actin cytoskeleton or on the number of
fenestrae per area could be detected (Fig. 2).
Discussion
It is well known that CB disrupts F-actin in various cell
types within 5 to 15 min after application. Previous stud-
ies on LSECs confirmed the rapidity of CB on the actin
cytoskeleton and the number of fenestrae when relatively
high doses of this drug were used, i.e., 10 micrograms/ml
(21 micromolar/L). In this study, however, we used CB at
a concentration of 0.025 microgram/ml and showed that
this concentration induces a moderate but significant
increase in the number of fenestrae in vitro (Figs. 1, 2).
Unfortunately, due to technical limitations we were not
able to load Aco-HSA liposomes with higher doses of CB,
thereby excluding full comparison between the results
obtained in this paper (Figs. 1,2,3) and the literature.
Based on the data gathered, we suggest that there is a dif-
ference in cellular processing of free CB (Fig. 1) versus CB-
Fluorescence- and scanning electron micrographs of cultured  LSECs treated with 0.025 microgram/ml CB for 2 hours (A)  Staining of LSECs with rhodamine-phalloidin shows a loss of  stress fibers Figure 1
Fluorescence- and scanning electron micrographs of cultured 
LSECs treated with 0.025 microgram/ml CB for 2 hours (A) 
Staining of LSECs with rhodamine-phalloidin shows a loss of 
stress fibers. Bar = 15 µm. (B) Detailed topology investiga-
tion of CB-treated LSECs reveals intact fenestrae grouped in 
sieve plates (→). Note that a moderate increase in the 
number of fenestrae could be detected (for comparison see 
also, figure 3). Bar = 1 µm
Effect of CB on the number of fenestrae per micrometer  squared in time Figure 2
Effect of CB on the number of fenestrae per micrometer 
squared in time. Solid line shows the effect of 0.025 micro-
gram/ml free CB on LSECs in vitro (* p < 0.05; means ± 
S.E.M); whereas the dashed line shows the effect of Aco-HSA 
CB-loaded liposomes in vivo at a final CB concentration of 
0.025 microgram/ml. The pointed line above shows the 
expected effect of 10 micrograms/ml CB on LSECs in vitro.
Fluorescence- and SEM images of LSECs in vitro (A-D) and in  vivo (E-F) treated with Aco-HSA (A, C, E) (control) and  with Aco-HSA CB-loaded liposomes (B, D, F) at a CB con- centration of 0.025 microgram/ml for two hours Figure 3
Fluorescence- and SEM images of LSECs in vitro (A-D) and in 
vivo (E-F) treated with Aco-HSA (A, C, E) (control) and 
with Aco-HSA CB-loaded liposomes (B, D, F) at a CB con-
centration of 0.025 microgram/ml for two hours. No signs of 
F-actin disruption could be observed in both conditions (A-
B) (compare with Fig. 1A) and fenestral number remained 
unchanged (C-D) (compare with Fig. 1B). Nucleus (N), 
Fenestrae (arrow). (E-F) SEM images of the sinusoidal lumen 
(S) and parenchymal cells (P). Fenestrae (arrow). No signifi-
cance difference in the number of fenestrae could be deter-
mined between the control (E) and rats injected with Aco-
HSA CB-loaded liposomes (F). Bars A-B = 15 µm; C-D = 2 
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loaded liposomes (Fig. 3). Aco-HSA-liposomes are taken
up very efficiently by LSECs via a scavenger receptor medi-
ated system [2]. Scavenger receptor mediated uptake is
followed by efficient lysosomal degradation as was also
shown for Aco-HSA liposomes. Therefore, we postulate
that CB is not able to exert its effect anymore on the
number of fenestrae after being in the lysosomal milieu.
On the other hand, we have previously shown that CB is
capable to inhibit the uptake of Aco-HSA liposomes in
LSECs. The initial uptake of CB-loaded liposomes may
inhibit further uptake of these liposomes, leaving the
intracellular concentration of CB below the value that can
be obtained with a free CB concentration of 0.025 micro-
gram/ml. In summary, the obtained data show that tar-
geted CB containing liposomes are not able to induce an
increase in the number of fenestrae both in vitro and in
vivo. This raises new questions regarding the uptake and
processing of liposomes within cells.
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